Yellow fever transmission could affect urban areas in Brazil, increasing the risk to travellers, especially during Carnival
ECDC issues new risk assessment in light of the yellow fever resurgence in Brazil (in particular in São Paulo) and the expected increasing flow of travellers during the upcoming Carnival.
Salmonella Agona outbreak: infant formula recall to reduce risk to public health
The widespread recall of several infant formula products made by a French processing company is likely to significantly reduce the risk of infants being infected by Salmonella Agona, according to the risk assessment published today by ECDC and the European Food Safety Authority (EFSA). However, as long as there are potentially contaminated products circulating, new cases may still be detected.
Measles in the EU/EEA: current outbreaks, latest data and trends – January 2018
Measles outbreaks continue to occur in a number of EU/EEA countries, and there is a risk of spread and sustained transmission in areas with susceptible populations. Since the beginning of 2016, 49 deaths due to measles have been reported in the EU,
Salmonella Agona outbreak associated with infant formula milk
On 6 December 2017, France reported an outbreak of Salmonella Agona in infants <1 years of age linked to consumption of infant milk formula based on an epidemiological investigation. Different brands of infant formulas from the same producer in France and distributed to different countries inside and outside the EU were implicated as the vehicle of infection in this outbreak.
Epidemiological update: hepatitis A outbreak in the EU/EEA mostly affecting men who have sex with men
Since the last epidemiological update on this multi-country hepatitis A outbreak published on 29 September 2017, 22 EU/EEA countries (Austria, Belgium, Croatia, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Ireland, Italy, Latvia, Luxembourg, Malta, the Netherlands, Norway, Portugal, Slovenia, Spain, Sweden and the United Kingdom-England & Wales) have reported 950 new outbreak-confirmed cases. Outbreak-confirmed cases are EU/EEA residents with laboratory-confirmed hepatitis A virus (HAV) genotype IA and a sequence with ≥99.3% homology to one of the three HAV genotype IA outbreak strains (VRD_521_2016; RIVM-HAV16-090; and V16-25801) based on overlapping fragments at the VP1-2a region.
European laboratories move forward towards stronger epidemic readiness for infectious disease threats.
The latest EULabCap data on assessing the public health laboratory capacities among 30 EU and EEA countries in 2016 reveal continuous improvement in reducing inequalities, with ten more countries reaching fair to high capability levels over the 4 years of monitoring.
Measles in the EU/EEA: current outbreaks, latest data and trends – December 2017
Measles outbreaks continue to occur in a number of EU/EEA countries, and there is a risk of spread and sustained transmission in areas with susceptible populations. Since the beginning of 2016, 48 deaths due to measles were reported in the EU.
Expert opinion on meningococcal B vaccine – information and suggestions to EU/EEA countries
The ECDC expert opinion provides information on the burden of serogroup B invasive meningococcal disease in the EU/EEA, includes general considerations for 4CMenB introduction such as vaccine immunogenicity, safety, cost-effectiveness, ease of implementation and areas for country collaboration, and highlights different options for vaccine introduction.
Yellow fever in Brazil: confirmed cases in urban areas in São Paulo and Rio de Janeiro
From July to October 2017 the Brazilian authorities reported three confirmed human cases of yellow fever - one in Rio de Janeiro and two in São Paulo State. One person died. In addition, several animal cases were detected in the urban area of São Paulo City. The national health authorities have started a vaccination campaign in São Paulo State.